ESG rating upgraded! Healthy Yuan Pharmaceutical Group interprets social responsibility with actions
Time Posted:2021-08-17 17:00
Recently, Morgan Stanley Capital International (MSCI), a world-renowned index compiler, released the latest news on its ESG rating, which aims to measure a company's resilience to ESG risks in terms of long-term development and financial capabilities. Joincare Pharmaceutical Group Industry Co., Ltd. (600380.SH)'s ESG (Environmental, Social, and Governance) rating has been upgraded from BB to BBB, reflecting improvements in scores related to environmental protection, human capital development, and accessible healthcare.
Time Posted:2021-08-16 15:49
Health Yuan was founded in Shenzhen Special Economic Zone in 1992 and became known to the Chinese people for its "Tai Tai Oral Liquid". From 1995 to 1997, Health Yuan completed its strategic transformation into the pharmaceutical field, gradually growing into an innovative and comprehensive group company covering the research and development, production, sales, and service of pharmaceutical and health products.
Time Posted:2021-08-10 19:01
Recently, Zhejiang University School of Management and Shenzhen Press Group's Deep New Communication Think Tank jointly released the "2021 China Listed Companies Innovation Index Report." The report selected 2384 China A-share listed companies as the evaluation objects, constructed an evaluation model based on two dimensions of innovation potential and innovation efficiency, and launched three rankings: "2020 China Listed Companies Innovation Index Top 500," "2020 China Listed Companies Innovation Potential Top 200," and "2020 China Listed Companies Innovation Efficiency Top 200."
Time Posted:2021-08-03 17:53
In June 2021, Chemical.AI, a research and technology company empowering chemistry with AI, announced strategic partnerships with CSPC Pharmaceutical Group and HealthGen Biotech, both dedicated to discovering and supporting leading pharmaceutical innovations and product development in China. The three parties will combine their respective strengths, including Chemical.AI's leading computer-aided retrosynthesis design system, and the process chemistry expertise and experience of CSPC Pharmaceutical and HealthGen Biotech, to develop process chemistry modules and promote process chemistry R&D using AI retrosynthesis technology.
Time Posted:2021-07-31 19:53
Recently, heavy rains in Henan Province have caused severe flooding and damage to infrastructure, resulting in significant casualties and property losses. Health & Medicine Group and Lizhu Pharmaceutical Group are deeply concerned about the health and medical needs of the affected people in Henan and have urgently donated a total of 20 million yuan in cash and supplies (10 million yuan in cash and 10 million yuan worth of medicine) to the China Red Cross Foundation to support relief efforts.
Time Posted:2021-07-23 18:55
Since July 17, the historically rare extreme and persistent heavy rainfall in Henan Province has caused serious waterlogging and other disasters in many parts of the province. The flood prevention situation is extremely severe, worrying the whole nation, and many parts of the country are providing assistance to Henan.
Time Posted:2021-07-22 18:51
On July 21, the annual 2021 Mises Conference kicked off at the Yunnan Kunming Yun'an Huidu International Convention Center. The much-anticipated highlight, the 2020 Top 100 Chinese Pharmaceutical Industry List, was grandly unveiled!
Time Posted:2021-07-14 17:04
According to a July 13 report by the Russian business newspaper Kommersant, Livzon Mabpharm Inc. (Zhuhai Livzon Mabpharm Biotech Co., Ltd.) recently submitted a registration application for its recombinant protein COVID-19 vaccine, V-01, to Russia.